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Involucrin is a major protein of the corni¢ed envelope
of keratinocytes that provides much of the structural
integrity of skin. Its expression is stimulated by a num-
ber of agents including calcium and 1,25-dihydroxy-
vitamin D3 that promote the di¡erentiation process
in keratinocytes. Within the distal regulatory region
of the involucrin promoter lies an AP-1 site and an
element homologous to other vitamin D response ele-
ments. In previous studies mutation of the AP-1 site
was found to reduce basal activity and block calcium
stimulation of the involucrin promoter, whereas the
vitamin D response element was not critical for cal-
cium regulation. In this study both elements proved to
be important for 1,25-dihydroxyvitamin D3 stimulation
of the involucrin promoter. Mutation of the AP-1 site
reduced basal activity and blocked 1,25-dihydroxyvita-
min D3 stimulation of the involucrin promoter. In
contrast, mutation of the vitamin D response element did
not reduce basal expression of the involucrin promoter
or prevent calcium stimulation of involucrin gene ex-
pression, but blocked 1,25-dihydroxyvitamin D3 stimu-
lation. The vitamin D response element from the
involucrin gene bound the vitamin D receptor and the
retinoid X receptor, but not the retinoic acid receptor,
in a speci¢c manner.We conclude that the AP-1 site and
the vitamin D response element in the involucrin pro-
moter play important roles in mediating the action of
1,25-dihydroxyvitamin D3 on involucrin expression,
but the vitamin D response element provides speci¢city
for the 1,25-dihydroxyvitamin D3 response lacking at
the AP-1 site. Key words: AP-1/involucrin/keratinocytes/
vitamin D receptor/vitamin D response element/PPARa/
LXR/dP-1/DR3/PBS. J Invest Dermatol 119:1109 ^1113,
2002
T
he observation that 1,25-dihydroxyvitamin D3
(1,25(OH)2D3) induces keratinocyte di¡erentiation
was ¢rst made by Hosomi et al (1983) and provided
a rationale for the previous and unexpected ¢nding
of 1,25(OH)2D3 receptors in the epidermis (Stumpf
et al, 1979). 1,25(OH)2D3 is likely to be an autocrine or paracrine
factor for epidermal di¡erentiation as it is produced by the kera-
tinocyte, but under normal circumstances keratinocyte produc-
tion of 1,25(OH)2D3 does not appear to contribute to circulating
levels (Bikle et al, 1986). The receptors for and the production of
1,25(OH)2D3 vary with di¡erentiation (Pillai et al, 1988a) in a
manner that suggests feedback regulation; both are reduced in
the later stages of di¡erentiation. The di¡erentiation pathway that
we have studied most directly is the formation of the corni¢ed
envelope, the structure within the keratinocyte that provides
much of the structural integrity of the skin. The corni¢ed envel-
ope is composed of a number of proteins including involucrin
that are cross-linked by the enzyme transglutaminase to form
the corni¢ed envelope (Simon and Green, 1984; Thacher and
Rice, 1985; Hohl, 1990). 1,25(OH)2D3 increases gene expression
and the mRNA and protein levels for involucrin and transgluta-
minase, and promotes corni¢ed envelope formation at subnano-
molar concentrations in precon£uent keratinocytes (Hosomi et al,
1983; Smith et al, 1986; McLane et al, 1990; Pillai and Bikle, 1991;
Su et al, 1994). The e¡ects of 1,25(OH)2D3 and calcium are addi-
tive and even synergistic in this e¡ect (Su et al, 1994). The involu-
crin gene has been cloned (Eckert and Green, 1986), and the
region responsible for its induction by calcium identi¢ed (Ng
et al, 2000). The calcium-responsive region contains an AP-1 site
that is essential not only for calcium responsiveness (Ng et al,
2000) but for induction of this gene by phorbol esters (Welter
et al, 1995) and the activated nuclear hormone receptors PPARa
(Hanley et al, 2000; Komuves et al, 2000) and LXR (Hanley et al,
2000). As shown in this study, the AP-1 site also is important for
the ability of 1,25(OH)2D3 to increase involucrin gene expression.
30 of the AP-1 site, however, and separated from it by an SP-1 site,
is a putative vitamin D response element (VDRE) containing
two half sites separated by three nucleotides (DR3). In previous
studies (Ng et al, 2000) this VDRE was shown not to be essential
for calcium or phorbol ester stimulation of involucrin expression.
In this study we demonstrate that this putative VDRE is func-
tional and like other DR3 VDREs binds the vitamin D receptor
(VDR) and retinoid X receptor (RXR). The close proximity of
theVDRE and the AP-1 site may explain the synergism between
calcium and 1,25(OH)2D3 in the regulation of the involucrin gene.
EXPERIMENTAL PROCEDURES
Cell culture Normal human keratinocytes were isolated from neonatal
human foreskins and grown in serum-free keratinocyte growth medium
(KGM, Clonetics, San Diego, CA) as described previously (Pillai et al,
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1988). Brie£y, keratinocytes were isolated from newborn human foreskins
by trypsinization (0.25% trypsin, 41C overnight), and primary cultures
were established in KGM containing 0.07 mM calcium. After 2 d the
calcium concentration was changed to 0.03 mM calcium, and unless
otherwise stated the ¢rst and second passage keratinocytes were grown in
this medium. All experiments used second passage keratinocytes. Details
regarding the addition of calcium and 1,25(OH)2D3 are found in the
¢gure legends and/or text for each experiment.
Construction of vectors The 3.7 kb fragment of the human involucrin
promoter (gift from Dr. Lorne B. Taichman) (2461 to þ1228 bp of
the involucrin gene, numbered with transcription start site as þ1) was
subcloned into a pGL-3 basic vector (Promega, Madison, WI) (Carroll
et al, 1993), linking it to the luciferase gene as previously described (Ng et al,
2000). The AP-1 site at 2114 to 2108 bp was mutated at base 2110
(TGAGTCA toTGAGcCA) using polymerase chain reaction (PCR) based
mutagenesis as previously described (Ng et al, 2000). In similar fashion the
putativeVDRE (2097 to2083) was mutated at 10 base pairs in both half
sites in a manner that created a BamHI site for screening purposes
(GGCAGATCTGGCAGA to caggacTCTGGatcc). Correct orientation of
the inserts with respect to the luciferase sequence was veri¢ed by
restriction enzyme analysis. All sequences were veri¢ed by automated
nucleotide sequencing using £uorescence dye terminators.
Transfection, selection, and luciferase assay Second passage
keratinocytes plated in 60 mm culture dishes were cotransfected with 2
mg of the various involucrinluciferase promoter constructs and 0.2 mg of
pRSV b-gal or pRL-TK using a polybrene method ( Jiang et al, 1991)
modi¢ed as previously described (Ng et al, 2000) or Superfect (Qiagen,
Valencia, CA). pRSV b-gal is a b-galactosidase expression vector that
contains a b-galactosidase gene that is driven by a Rous sarcoma virus
promoter and enhancer, whereas pRL-TK is a renilla luciferase construct
driven by a thymidine kinase promoter. These constructs were used as
internal controls to normalize for transfection e⁄ciency. Following the
addition of calcium as calcium chloride (to a ¢nal concentration of
1.2 mM) and/or 1,25(OH)2D3 the cells were lysed 24^48 h later, and the
cell extracts were assayed for luciferase activity using the Luciferase Assay
System (Promega, Madison, WI) and b-galactosidase activity using the
Galacto-LightTM kit (TROPIX, Bedford, MA). Every experiment was
done in triplicate and was repeated at least three times with di¡erent
keratinocyte preparations.
Northern analysis Total RNAwas isolated from the keratinocytes using
the STAT-60 kitTM (Tel.Test ‘B’, Friendswood, TX), according to the
procedures recommended by the manufacturer. The isolated RNA (30 mg
per lane) was electrophoresed through a 0.8% agarose-formaldehyde gel,
transferred to a nylon membrane (Hybond-Nþ ; Amersham, Arlington
Heights, IL) using PosiBlot 30^30 Pressure Blotter (Stratagene, La Jolla,
CA), and immobilized by baking the membrane at 801C for 2 h. The
human involucrin cDNA probe (gift from Dr. Robert Rice) was labeled
with 32P-dCTP (Amersham, Arlington Heights, IL) by Random Prime-
IT II labeling kit (Stratagene) and puri¢ed by NucTrap Probe Puri¢cation
Columns (Stratagene, La Jolla, CA). The membrane was prehybridized and
hybridized in 5 sodium citrate/chloride bu¡er (SSC), 5Denhardt’s
solution, 0.5% sodium dodecyl sulfate (SDS), and 20 mg per ml salmon
sperm DNA with the 32P-labeled human involucrin cDNA. Following
hybridization at 651C overnight, the membrane was washed in solutions
with decreasing ionic strength and increasing temperature, to a ¢nal
stringency of 0.1SSC, 0.1% SDS, at 651C. The [32P]cDNA-mRNA
hybrids were visualized by exposing to X-ray ¢lm. The human involucrin
mRNAwas normalized to the levels of 18S ribosomal RNA in the same
RNA blots as determined by rehybridization of the ¢lter with a 32P-end-
labeled cDNA for 18S RNA.
Western analysis Keratinocytes were washed twice with phosphate-
bu¡ered saline (PBS) and then incubated in RIPA lysis bu¡er (50 mM
HEPES pH 7.4, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 1 mM
ethylenediamine tetraacetic acid, 20 mg per ml phenylmethylsulfonyl
£uoride, 1 mg per ml leupeptin, 1 mg per ml pepstatin A, and 2 mg per ml
aprotinin) for 5 min. Cells were scraped into microfuge tubes, incubated
on ice for 15 min, and pelleted by centrifugation. The supernatant was
collected. The protein concentration of the lysate was measured with the
BCA Protein Assay Kit (Pierce, Rockford, IL). Equal amounts of protein
(50 mg) were then electrophoresed through 7.5% polyacrylamide gels at
200 V for 30 min and electroblotted onto polyvinylidene di£uoride
membranes (0.2 mm, Bio-Rad Laboratories, Hercules, CA) in an
electroblotting bu¡er (25 mM Tris, 192 mM glycine, 5% methanol) at
130 V for 2 h. Following incubation in blocking bu¡er (100 mM Tris base,
150 mMNaCl, 5% nonfat milk, and 0.5% Tween-20), the blot was incubated
with a polyclonal mouse antihuman involucrin antibody (Sigma), dilu-
tion 1:2000, overnight at 41C. After washes in the blocking bu¡er, the
membranes were incubated for 1 h with antimouse IgG secondary
antibody conjugated to horseradish peroxidase (Amersham, Arlington
Heights, IL) diluted 1:5000 in the blocking bu¡er. Following a second
series of washes, bound antibody complexes were visualized using
the SuperSignal ULTRA Chemiluminescent Kit (Pierce, Rockford, IL)
and subsequent exposure to X-ray ¢lm. The speci¢c bands on the
autoradiograms were quantitated by densitometry.
DNAmobility shift assay The nuclear extracts were made from keratino-
cytes according to the method described by Abmayr and Workman (1994).
The synthetic oligonucleotide used for the DNA mobility shift assay
contained the wild-type VDRE sequence, part of the SP-1 sequence, but
not the AP-1 sequence (50 -GCGGGAGGCAGATCTGGCAGATACTGA-30)
and was end-labeled by T4 polynucleotide kinase. Competing oligo-
nucleotides included the wild-type sequence used as probe, the mutated
VDRE sequence (50 -GCGGGAcaggacTCTGGatccTACTGA-30), and the
VDRE at region ^152 to ^172 in the human 24-hydroxylase gene. The
DNA-protein reactions were performed in a total of 17 ml: nuclear extracts
(12 mg protein) were incubated with 2 mg of poly(dI:dC) (Pharmacia) and
10,000 cpm of 32P-labeled probe in 10 ml binding bu¡er (20 mM HEPES,
pH 7.9, 20% glycerol, 50 mM KCl, 0.5 mM dithiothreitol) at 301C for
25 min. Unlabeled competitors were added in 100 molar excess before
incubation. In the super gel-shift reaction, a polyclonal antiVDR antibody,
polyclonal retinoic acid receptor g1 antibody, or polyclonal RXRa anti-
body (A⁄nity Bioreagents) was added to the DNAprotein reaction and
incubated for an additional 25 min. ProteinDNA complexes were
electrophoresed in a 6% nondenaturing polyacrylamide gel in 1gel-shift
running bu¡er (50 mM Tris, 380 mM glycerin, 2 mM ethylenediamine
tetraacetic acid, pH 8.5), and the bands were identi¢ed by autoradiography.
RESULTS
The ability of 1,25(OH)2D3 to increase the mRNA and protein
levels of involucrin is shown in Fig 1. In this experiment
1,25(OH)2D3 from 10
^11 to 10^8 M was added to precon£uent
keratinocytes 24 h (for mRNA) or 48 h (for protein) before the
cells were harvested for mRNA and protein assessment of invo-
lucrin levels. As shown, 1,25(OH)2D3 has a dose-dependent abil-
ity to increase the mRNA and protein levels of involucrin.
To examine more closely the direct e¡ect of 1,25(OH)2D3 on
gene expression we transfected keratinocytes with a promoter
construct of the involucrin gene coupled to a luciferase reporter
(Fig 2). This construct contained the 50 promoter, the noncoding
Figure1. 1,25(OH)2D3 increases involucrin mRNA and protein levels.
Second passage keratinocytes were grown in 0.03 mM calcium for 4 d
at which point the indicated concentrations of 1,25(OH)2D3 or vehicle (1%
ethanol) were added for an additional 24 h (mRNA) or 48 h (protein) incuba-
tion. The involucrin mRNA levels (top panel) were determined by northern
analysis; the involucrin protein levels (bottom panel) were determined by
Western analysis.
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exon 1, and the intron. The keratinocytes were incubated in 0.03
or 1.2 mM calcium to which 10^9 M 1,25(OH)2D3 or vehicle (1%
ethanol) was added at the time of the calcium switch. The cells
were harvested 48 h later. Calcium has a major stimulatory e¡ect
on the involucrin promoter, increasing its expression 15-fold in
this experiment. 1,25(OH)2D3 further increases involucrin pro-
moter activity 2-fold at both calcium concentrations, however
(Fig 2).
In examining a series of deletion mutants generated during our
previous search for the calcium response region (Ng et al, 2000), it
became clear that the e¡ect of 1,25(OH)2D3 was mediated by the
50 regulatory region of the promoter (2461 to 1881 bp, data
not shown). In previous studies this region of the involucrin pro-
moter has been shown to be important for its regulation by a
number of agents including calcium and phorbol esters. As
shown in Fig 3 this region contains in close proximity an AP-1
site, an SP-1 site, and a previously overlooked putative VDRE.
When we tested the responsiveness of an involucrin promoter
construct containing a point mutation in the AP-1 site, the basal
levels of promoter activity fell to 20% of the wild-type levels,
and 1,25(OH)2D3 failed to increase the activity of the mutated
promoter (Fig 4). This same mutation blocks calcium and phor-
bol ester stimulation of the involucrin promoter as we have pre-
viously reported (Ng et al, 2000). These results suggest that the
AP-1 site is required for 1,25(OH)2D3 stimulation of the involu-
crin promoter, but the requirement may be indirect.
The adjacent VDRE suggested a more direct means by which
1,25(OH)2D3 could stimulate the involucrin gene. Therefore, we
mutated the VDRE within the context of the 3.7 kb involucrin
promoter construct and evaluated its response to 1,25(OH)2D3.
The results are shown in Fig 5. In this experiment the cells trans-
fected with the wild-type orVDRE mutant (DR3 mutant) were
incubated in 0.03 mM calcium to which 108 M 1,25(OH)2D3 or
vehicle was added for 24 h before harvesting the cells for the lu-
ciferase assay. Unlike the AP-1 mutation, basal levels of involu-
crin promoter activity were not a¡ected; however, the ability of
1,25(OH)2D3 to increase involucrin promoter activity was com-
pletely lost. In contrast, calcium and phorbol ester responsiveness
was retained. In this experiment we used a suboptimal dose of
phorbol myristate acetate (10 M) to enhance our chances of seeing
an e¡ect of this mutation on responsiveness, but no alteration was
observed. Although the data in Fig 5 do indicate a partial reduc-
tion in calcium responsiveness caused by the VDRE mutation,
this has not been a consistent observation as shown by our pre-
vious results that the VDRE is not required for calcium stimula-
tion of the involucrin promoter (Ng et al, 2000).
To determine that the putative VDRE in the involucrin pro-
moter interacted directly with theVDR, the DNA mobility shift
assay with theVDRE as probe was performed as shown in Fig 6.
This probe contained theVDRE but not the AP-1 site and only a
portion of the SP-1 site. Nuclear extracts from the keratinocytes
showed a prominent retarded band that was competed out with
the unlabeled wild-type oligonucleotide and an oligonucleotide
containing the VDRE from the human 24-hydroxylase gene,
but was una¡ected by an oligonucleotide containing the mutated
VDRE. When the nuclear extract was incubated with an
antibody to VDR or RXRa, the band was completely shifted
to a higher molecular size consistent with VDR and RXRa
binding to the VDRE. In contrast, no supershift was observed
when an antibody to retinoic acid receptor g was employed.
DISCUSSION
Involucrin is a major component of the corni¢ed envelope, and
thus plays an important role in the di¡erentiated function of the
epidermis. Not surprisingly its expression in the epidermis is
tightly linked to the di¡erentiation status of the keratinocyte.
Involucrin expression increases as the keratinocyte leaves the
stratum basale to enter the di¡erentiation pathway leading ulti-
mately to its death and incorporation into the stratum corneum.
As such involucrin is a widely used marker for keratinocyte
di¡erentiation, and its expression is modulated by agents that
regulate keratinocyte di¡erentiation. A number of these agents
including the best studied  calcium and phorbol esters  have
Figure 2. 1,25(OH)2D3 stimulates involucrin promoter activity. The
keratinocytes were grown for 3 d in 0.03 mM calcium and then transfected
with the 3.7 kb involucrin promoter-luciferase construct and pRSV b-gal
construct using the polybrene/glycerol method as described in Experimental
Procedures. Twenty-four hours later the cells were either switched to 1.2 mM
calcium or maintained at 0.03 mM calcium to which 10^9 M 1,25(OH)2D3
or vehicle (1% ethanol) was added for an additional 48 h.The results of the
luciferase assay were normalized to galactosidase activity.The error bars en-
close mean 7 SD of triplicate determinations. npo0.01 compared to
vehicle.
Figure 3. The sequence of the involucrin pro-
moter containing the distal AP-1 site, the ad-
jacent SP-1 site, and the putativeVDRE.
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been shown to act at least in part through the distal AP-1 site in
the involucrin promoter (Welter et al, 1995; Hanley et al, 2000b;
Komuves et al, 2000; Ng et al, 2000). The involucrin promoter
has ¢ve AP-1 sites, but only the proximal and distal sites respond
to phorbol esters (Welter et al, 1995), and only the distal site re-
sponds to calcium (Ng et al, 2000). Mutations in the distal AP-1
site reduce basal activity and block the ability of calcium, phorbol
esters, PPARa agonists, and LXR agonists to stimulate involu-
crin gene expression (Welter et al, 1995; Hanley et al, 2000;
Komuves et al, 2000; Ng et al, 2000). Thus the distal AP-1 site is
clearly important for involucrin gene expression. Adjacent to the
distal AP-1 site is an SP-1 site that appears to increase AP-1 factor
binding to the AP-1 site and enhance its function (Banks et al,
1998), although the SP-1 site in and of itself is not su⁄cient to
drive involucrin gene expression. Both calcium and phorbol es-
ters alter the levels of AP-1 factors and their binding to the distal
involucrin AP-1 site in keratinocytes (Welter et al, 1995; Ng et al,
2000). Furthermore, the regulation of the involucrin gene by
calcium and phorbol esters is blocked by inhibitors of protein
kinase C that would be expected to block these changes in the
AP-1 factors (Denning et al, 1995;Welter et al, 1995; Ng et al, 2000).
1,25(OH)2D3 induces di¡erentiation in keratinocytes (Bikle
and Pillai, 1993). These cells not only contain the VDR (Pillai
et al, 1988a), but are prodigious producers of this hormone (Bikle
et al, 1986). Among the genes induced by 1,25(OH)2D3 in kerati-
nocytes is involucrin (Su et al, 1994). The mechanism for its in-
duction by 1,25(OH)2D3 has remained obscure, however. As
1,25(OH)2D3 increases the intracellular concentration of calcium
within the keratinocyte (Pillai and Bikle, 1991), one possibility is
that the stimulation of involucrin expression is mediated by
Figure 5. Mutation of the VDRE blocks 1,25(OH)2D3 stimulation
of the involucrin promoter but not that of calcium or phorbol
esters without a¡ecting basal activity. Keratinocytes were grown in
0.03 mM calcium and then transfected using Superfect with the wild-type
involucrin promoter-luciferase construct (wild-type) or the comparable
construct in which a 10 bp mutation in the putative VDRE was made
(DR3 mutation). In each case pRL-TKwas used for normalization as de-
scribed in Experimental Procedures. Twenty-four hours after transfection the
cells were incubated with 10^8 M 1,25(OH)2D3 or vehicle (1% ethanol) in
0.03 mM calcium, 1.2 mM calcium (Ca), or 10 M phorbol myristate acetate
(PMA) in 0.03 mM calcium for an additional 24 h before assessing lucifer-
ase activity. The error bars enclose mean7SD of triplicate determinations.
npo0.01 compared to vehicle.
Figure 6. DNA mobility shift assays showing the speci¢c binding of
VDR and RXR to the VDRE of the involucrin gene. The sequence
of the probe is found in Experimental Procedures and included theVDRE and
part of the SP-1 site, but excluded the AP-1 site. A dominant retarded band
is observed with nuclear extracts from keratinocytes (top panel). 100 molar
excess of the unlabeled wild-type sequence (W) eliminated binding as did
the VDRE sequence from the 24-hydroxylase gene (24OH), but the se-
quence containing the mutatedVDRE (M) did not. Antibodies to RXRa
and VDR supershifted the binding, but anti-retinoic acid receptor g had
no e¡ect.
Figure 4. Mutation of the distal AP-1 site lowers basal activity and
blocks 1,25(OH)2D3 stimulation of the involucrin promoter. Kerati-
nocytes were grown in 0.03 mM calcium and then transfected with the
wild-type involucrin promoterluciferase construct (WT) or the compar-
able construct in which a point mutation in the distal AP-1 site was made
(mut AP-1). In each case pRSV b-gal was used for normalization as de-
scribed in the legend to Fig 2. Twenty-four hours after transfection the
cells were incubated with 10^9 M 1,25(OH)2D3 or vehicle (1% ethanol)
for an additional 24 h before assessing luciferase activity. The error bars
enclose mean 7 SD of triplicate determinations. npo0.01 compared to
vehicle.
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calcium.The e¡ect of 1,25(OH)2D3 on intracellular calcium levels
could readily be explained by the ability of 1,25(OH)2D3 to in-
crease the levels of the calcium sensing receptor (Ratnam et al,
1999). Furthermore, 1,25(OH)2D3 induces members of the
phospholipase C family (Pillai et al, 1995), which by hydrolyz-
ing phosphatidyl inositol bis phosphate increase inositol tris
phosphate and diacyl glycerol leading to release of calcium from
intracellular stores and activation of protein kinase C, respec-
tively. Either event would be expected to stimulate involucrin
gene expression and be blocked by mutations in the AP-1 site.
Our observation that mutation of the distal AP-1 blocks
1,25(OH)2D3 stimulation of the involucrin promoter is consistent
with these mechanisms of action.
A more appealing mechanism, however, emanates from our
observation of a putative VDRE in the involucrin gene proximal
to the AP-1 site. This VDRE is a perfect direct repeat (GGCAGA
for each half site) with a three nucleotide intervening sequence
making it a DR3. It is not identical to any other functional
VDRE to our knowledge, but known functional VDREs show
substantial variation (Haussler et al, 1998). The involucrin VDRE
has the sequence A/GGnnnA found for each half site in most
VDREs described to date, and these speci¢c nucleotides may be
important for the binding to theVDR and RXR.ThisVDRE is
clearly functional within the context of the involucrin promoter
in that mutations in the half sites block 1,25(OH)2D3 responsive-
ness. Furthermore, both VDR and RXR bind to this VDRE as
expected for a functional VDRE of the DR3 class (Haussler et al,
1998). Unlike distal AP-1 site mutations, mutation of the VDRE
does not alter basal activity or prevent calcium and phorbol ester
responsiveness of the involucrin promoter. As we previously
showed (Ng et al, 2000), the VDRE is not required for calcium
stimulated binding of AP-1 factors to the AP-1 site; as we show
in this report the AP-1 site is not required for binding of VDR
and RXR to the VDRE. These results are consistent with the
concept that the distal AP-1 site is required for basal activity and
the regulation of involucrin promoter activity by a variety of
factors, whereas the VDRE serves the more speci¢c purpose of
modulation of involucrin gene expression by 1,25(OH)2D3.
Whether the VDRE and the AP-1 and/or SP-1 site interact to
promote involucrin gene expression is not clear at this stage. As
shown in this report, 1,25(OH)2D3 can enhance the ability of cal-
cium to stimulate involucrin promoter activity. The degree of en-
hancement is modest (2^3-fold) compared to the stimulation
generally observed by calcium, but is additive to the regulation
by calcium suggesting an independent mechanism. This result is
consistent with nuclear run on results directly assessing calcium
and 1,25(OH)2D3 regulated transcription of the involucrin gene
reported earlier (Su et al, 1994). This degree of stimulation of tran-
scription by 1,25(OH)2D3 is less than expected based on the in-
creases in mRNA and protein levels following 1,25(OH)2D3
administration (Fig 1). These results imply both transcriptional
and post-transcriptional control, a situation also observed for
1,25(OH)2D3 induction of calbindins (Christakos et al, 1992). In
fact we (Su et al, 1994) previously reported that both calcium and
1,25(OH)2D3 altered the half-life of the mRNA suggesting at
least one post-transcriptional mechanism at work. In that report
(Su et al, 1994), we also noted a synergism between calcium and
1,25(OH)2D3 on involucrin transcription as well as mRNA levels
within the ¢rst 24 h after the calcium switch. Directly testing this
interaction may be di⁄cult because alterations in the AP-1 site
have such profound e¡ects on involucrin gene expression. Never-
theless, our results indicate that theVDRE in the involucrin pro-
moter is functional and is likely to contribute to the regulation of
the involucrin gene by 1,25(OH)2D3.
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